ASHLEY METZGAR: Open Payments
NPI 1477850865 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 60 payments from 14 companies in 2025. Trend: 2023 $1,255 · 2024 $1,137 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $275 |
| Novo Nordisk Inc | 8 | $165 |
| Lilly USA, LLC | 7 | $143 |
| ABBVIE INC. | 7 | $139 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| Exact Sciences Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Astellas Pharma US Inc | 2 | $42 |
| Amgen Inc. | 2 | $31 |
Products named: MOUNJARO, NURTEC ODT, PREVNAR 20, Kerendia, Wegovy, Ozempic, ELIQUIS, UBRELVY.
Industry payments across FL — which companies pay providers there.
